Table 2

Partner and partnership characteristics, by index client (IC) subgroup (n=8448)

CharacteristicsAll named partners
n (col %)
Partners of ICs with recent HIV diagnosis*
n (col %)
Partners of ICs with established HIV diagnosis†
n (col %)
P value‡Partners of PWID ICs
n (col %)
Partners of MSM ICs
n (col %)
P value§
Total count8448293155171330153
Age (median, IQR)38 (31–45)37 (30–44)38 (32–45)<0.00138 (32–44)34 (26.5–41)0.21
Partner sex
 Male4390 (52.0)1444 (49.3)2946 (53.4)<0.001534 (40.2)136 (88.9)<0.001
 Female4058 (48.0)1487 (50.7)2571 (46.6)796 (59.8)17 (11.1)
Type of partnership
 Sexual7490 (88.7)2494 (85.1)4996 (90.6)<0.001890 (66.9)151 (98.7)<0.001
 Needle sharing391 (4.6)165 (5.6)226 (4.1)391 (29.4)0 (0.0)
 Biological child567 (6.7)272 (9.3)295 (5.3)49 (3.7)2 (1.3)
Partner disposition
 IPV concern (partner not contacted)27 (0.3)12 (0.4)15 (0.3)<0.0010 (0.0)0 (0.0)<0.001
 Partners already known HIV+ and enrolled on ART1327 (15.7)280 (9.6)1047 (19.0)85 (6.4)26 (17.0)
 Partners already known HIV+ but not already linked to ART162 (1.9)80 (2.7)82 (1.5)31 (2.3)1 (0.7)
 Partners newly diagnosed with HIV976 (11.6)651 (22.2)325 (5.9)242 (18.2)22 (14.4)
 Partners newly diagnosed HIV negative4045 (47.9)1225 (41.8)2820 (51.1)820 (61.7)69 (45.1)
 Partners not reached within 60 days1911 (22.6)683 (23.3)1228 (22.3)152 (11.4)35 (22.9)
Partner notification method¶
 Patient referral5119 (72.2)1842 (69.8)3277 (73.6)0.005889 (71.4)88 (69.3)0.15
 Provider referral554 (7.8)217 (8.2)337 (7.6)90 (7.2)10 (7.9)
 Contract referral70 (1.0)32 (1.2)38 (0.9)8 (0.6)1 (0.8)
 Joint referral1351 (19.0)548 (20.8)803 (18.0)258 (20.7)28 (22.0)
  • *ICs with recent HIV diagnosis are those with up to 6 months from HIV diagnosis to date when IT was accepted.

  • †ICs with established HIV diagnosis are those with more than 6 months from HIV diagnosis to date when IT was accepted.

  • ‡P value for comparison of partnership attributes among ICs with recent versus established HIV diagnoses, based on Wilcoxon rank-sum test (for IC age) or χ2 test of independence (for all other characteristics).

  • §P value for comparison of partnership attributes among key population (PWID or MSM) versus non-key population IC subgroups, based on Wilcoxon-rank sum test (for IC age) or χ2 test of independence (for all other characteristics).

  • ¶Among partners with no IPV concern and not already known HIV+ and enrolled on ART.

  • ART, antiretroviral therapy; IPV, intimate partner violence; MSM, men who have sex with men; PWID, people with current or past injection drug use.